Market Introduction
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.
Market Overview and Dynamics
The Asia Pacific antacids market is expected to reach US$ 3,255.05 million in 2027 from US$ 2,287.19 million in 2019. The market is estimated to grow with a CAGR of 4.6% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the increasing innovative product launches by market players and the higher incidence of the obese population. However, the market is expected experiencing slow growth during the forecast period owing to the stringent regulatory norms and several challenges associated with gastrointestinal diseases.
Key Market Segments
Based on dosage form, the antacids market is segmented into tablet, liquid, and others. Based on drug class, the antacids market is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. Based on distribution channel, the antacids market, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
Major Sources and Companies Listed
Some of the major primary and secondary sources for antacids market included in the report are National Center for Health Statistics (NCHS), the India Brand Equity Foundation (IBEF), the Australian Self Medication Industry (ASMI), and others.
Reasons to buy the report
ASIA PACIFIC ANTACIDS MARKET SEGMENTATION
By Drug Class
By Distribution Channel
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,287.19 Million |
| Market Size by 2027 | US$ 3,255.05 Million |
| CAGR (2020 - 2027) | 4.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Dosage Form
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Antacids Market is valued at US$ 2,287.19 Million in 2019, it is projected to reach US$ 3,255.05 Million by 2027.
As per our report Asia Pacific Antacids Market, the market size is valued at US$ 2,287.19 Million in 2019, projecting it to reach US$ 3,255.05 Million by 2027. This translates to a CAGR of approximately 4.6% during the forecast period.
The Asia Pacific Antacids Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Antacids Market report:
The Asia Pacific Antacids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Antacids Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Antacids Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Antacids Market
